Hypoxia-induced deoxycytidine kinase expression contributes to apoptosis in chronic lung disease

FASEB Journal

Volumn 27, Issue 5, 2013, Pages 2013-2026

  Weng, Tingting ^a   Karmouty Quintana, Harry ^a   Garcia Morales, Luis J ^b   Molina, Jose G ^a   Pedroza, Mesias ^a   Bunge, Raquel R ^b   Bruckner, Brian A ^b,c   Loebe, Matthias ^b,c   Seethamraju, Harish ^c   Blackburn, Michael R ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Adenosine deaminase; COPD; Deoxyadenosine; Emphysema

Indexed keywords

ADENOSINE DEAMINASE; CASPASE 3; CASPASE 7; DEOXYCYTIDINE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERIAL OXYGEN TENSION; ARTICLE; CELL INFILTRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEAMINATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXPIRATORY FLOW; FORCED VITAL CAPACITY; HUMAN; HUMAN CELL; HYPOXIA; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION; UPREGULATION;

2-CHLOROADENOSINE; ADENOSINE DEAMINASE; ANIMALS; ANOXIA; APOPTOSIS; CELLS, CULTURED; DEOXYADENINE NUCLEOTIDES; DEOXYADENOSINES; DEOXYCYTIDINE KINASE; HUMANS; MICE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; UP-REGULATION;

MUS;

EID: 84877151416     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-222067     Document Type: Article

References (46)

1. Ge, Y., Jensen, T. L., Matherly, L. H., and Taub, J. W. (2003) Physical and functional interactions between USF and Sp1 proteins regulate human deoxycytidine kinase promoter activity. J. Biol. Chem. 278, 49901-49910
2. Zhou, Y., Schneider, D. J., and Blackburn, M. R. (2009) Adenosine signaling and the regulation of chronic lung disease. Pharmacol. Therap. 123, 105-116
3. Koeppen, M., Eckle, T., and Eltzschig, H. K. (2011) The hypoxia-inflammation link and potential drug targets. Curr. Opin. Anaesthesiol. 24, 363-369
4. Demedts, I. K., Demoor, T., Bracke, K. R., Joos, G. F., and Brusselle, G. G. (2006) Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir. Res. 7, 53
5. Blackburn, M. R., Aldrich, M., Volmer, J. B., Chen, W., Zhong, H. Y., Kelly, S., Hershfield, M. S., Datta, S. K., and Kellems, R. E. (2000) The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities. J. Biol. Chem. 275, 32114-32121
6. Zhou, Y., Murthy, J. N., Zeng, D. W., Belardinelli, L., and Blackburn, M. R. (2010) Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Plos One 5, e9224
7. Blackburn, M. R. (2003) Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol. Sci. 24, 66-70
8. Riedl, S. J., and Salvesen, G. S. (2007) The apoptosome: signalling platform of cell death. Nat. Rev. Mol. Cell Biol. 8, 405-413
9. Blackburn, M. R., and Kellems, R. E. (2005) Adenosine deaminase deficiency: Metabolic basis of immune deficiency and pulmonary inflammation. Advances Immunol. 86, 1-41
10. Cohen, A., Barankiewicz, J., Lederman, H. M., and Gelfand, E. W. (1983) Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J. Biol. Chem. 258, 2334-2340
11. Spasokoukotskaja, T., Arner, E. S., Brosjo, O., Gunven, P., Juliusson, G., Liliemark, J., and Eriksson, S. (1995) Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues. Eur. J. Cancer. 31A, 202-208
12. Toy, G., Austin, W. R., Liao, H. I., Cheng, D. H., Singh, A., Campbell, D. O., Ishikawa, T. O., Lehmann, L. W., Satyamurthy, N., Phelps, M. E., Herschman, H. R., Czernin, J., Witte, O. N., and Radu, C. G. (2010) Requirement for deoxycytidine kinase in T and B lymphocyte development. Proc. Natl. Acad. Sci. U. S. A. 107, 5551-5556
13. Keszler, G., Spasokoukotskaja, T., Csapo, Z., Virga, S., Staub, M., and Sasvari-Szekely, M. (2004) Selective increase of dATP pools upon activation of deoxycytidine kinase in lymphocytes: implications in apoptosis. Nucleosides Nucleotides Nucleic Acids 23, 1335-1342
14. Wakamiya, M., Blackburn, M. R., Jurecic, R., McArthur, M. J., Geske, R. S., Cartwright, J., Mitani, K., Vaishnav, S., Belmont, J. W., Kellems, R. E., Finegold, M. J., Montgomery, C. A., Bradley, A., and Caskey, C. T. (1995) Disruption of the adenosine-deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc. Natl. Acad. Sci. U. S. A. 92, 3673-3677
15. Corti, M., Brody, A. R., and Harrison, J. H. (1996) Isolation and primary culture of murine alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 14, 309-315
16. Joachims, M. L., Marble, P. A., Laurent, A. B., Pastuszko, P., Paliotta, M., Blackburn, M. R., and Thompson, L. F. (2008) Restoration of adenosine deaminase-deficient human thymocyte development in vitro by inhibition of deoxynucleoside kinases. J. Immunol. 181, 8153-8161
17. Blackburn, M. R., and Kellems, R. E. (1996) Regulation and function of adenosine deaminase in mice. Prog. Nucleic Acid Res. 55, 195-226
18. Chen, Y. R., Dai, A. G., Hu, R. C., and Kong, C. C. (2012) [The expression of hypoxia-inducible factor-1alpha and its hydroxylases in pulmonary arteries of patient with chronic obstructive pulmonary disease]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 28, 234-238
19. Jiang, H., Zhu, Y., Xu, H., Sun, Y., and Li, Q. (2010) Activation of hypoxia-inducible factor-1 via nuclear factor-B in rats with chronic obstructive pulmonary disease. Acta Biochim. Biophys. Sin. (Shanghai) 42, 483-488
20. Hart, M. L., Grenz, A., Gorzolla, I. C., Schittenhelm, J., Dalton, J. H., and Eltzschig, H. K. (2011) Hypoxia-inducible factor-1-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5=-nucleotidase (CD73) and the A2B adenosine receptor. J. Immunol. 186, 4367-4374
21. Geutjes, E. J., Tian, S., Roepman, P., and Bernards, R. (2012) Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs. Breast Cancer Res. Treat 131, 809-818
22. Sigmond, J., Bergman, A. M., Leon, L. G., Loves, W. J., Hoebe, E. K., and Peters, G. J. (2010) Staurosporine increases toxicity of gemcitabine in non-small cell lung cancer cells: role of protein kinase C, deoxycytidine kinase and ribonucleotide reductase. Anticancer Drugs 21, 591-599
23. Sebastiani, V., Ricci, F., Rubio-Viqueira, B., Kulesza, P., Yeo, C. J., Hidalgo, M., Klein, A., Laheru, D., and Iacobuzio-Donahue, C. A. (2006) Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survival. Clin. Cancer Res. 12, 2492-2497
24. Robak, T. (2005) Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies. Drugs Aging 22, 983-1012
25. Jones, J., Takeda, A., Tan, S. C., Cooper, K., Loveman, E., and Clegg, A. (2009) Gemcitabine for the treatment of metastatic breast cancer. Health Technol. Assess. 13 (Suppl. 2), 1-7
26. Hilbig, A., and Oettle, H. (2008) Gemcitabine in the treatment of metastatic pancreatic cancer. Expert Rev. Anticancer Ther. 8, 511-523
27. Girard, N., and Mornex, F. (2007) [Gemcitabine and radiotherapy in non-small cell lung cancer: dolce vita at last!]. Bull. Cancer 94 (Spec. No. Actualites), S127-S133
28. Kasahara, Y., Tuder, R. M., Taraseviciene-Stewart, L., Le Cras, T. D., Abman, S., Hirth, P. K., Waltenberger, J., and Voelkel, N. F. (2000) Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 106, 1311-1319
29. Grenz, A., Homann, D., and Eltzschig, H. K. (2011) Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia. Antioxid. Redox Signal. 15, 2221-2234
30. Eltzschig, H. K., Kohler, D., Eckle, T., Kong, T., Robson, S. C., and Colgan, S. P. (2009) Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 113, 224-232
31. Li, X., Zhou, T., Zhi, X., Zhao, F., Yin, L., and Zhou, P. (2006) Effect of hypoxia/reoxygenation on CD73 (ecto-5=-nucleotidase) in mouse microvessel endothelial cell lines. Microvasc. Res. 72, 48-53
32. Joachims, M. L., Marble, P., Knott-Craig, C., Pastuszko, P., Blackburn, M. R., and Thompson, L. F. (2008) Inhibition of deoxynucleoside kinases in human thymocytes prevents dATP accumulation and induction of apoptosis. Nucleosides Nucleotides Nucleic Acids 27, 816-820
33. Csapo, Z., Keszler, G., Safrany, G., Spasokoukotskaja, T., Talianidis, I., Staub, M., and Sasvari-Szekely, M. (2003) Activation of deoxycytidine kinase by-irradiation and inactivation by hyperosmotic shock in human lymphocytes. Biochem. Pharmacol. 65, 2031-2039
34. Van Den Neste, E., Smal, C., Cardoen, S., Delacauw, A., Frankard, J., Ferrant, A., Van den Berghe, G., and Bontemps, F. (2003) Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes. Biochem. Pharmacol. 65, 573-580
35. Spasokoukotskaja, T., Sasvari-Szekely, M., Hullan, L., Albertioni, F., Eriksson, S., and Staub, M. (1998) Activation of deoxycytidine kinase by various nucleoside analogues. Adv. Exp. Med. Biol. 431, 641-645
36. Synnestvedt, K., Furuta, G. T., Comerford, K. M., Louis, N., Karhausen, J., Eltzschig, H. K., Hansen, K. R., Thompson, L. F., and Colgan, S. P. (2002) Ecto-5=-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110, 993-1002
37. Thompson, L. F., Eltzschig, H. K., Ibla, J. C., Van De Wiele, C. J., Resta, R., Morote-Garcia, J. C., and Colgan, S. P. (2004) Crucial role for ecto-5=-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200, 1395-1405
38. Eltzschig, H. K., Abdulla, P., Hoffman, E., Hamilton, K. E., Daniels, D., Schonfeld, C., Loffler, M., Reyes, G., Duszenko, M., Karhausen, J., Robinson, A., Westerman, K. A., Coe, I. R., and Colgan, S. P. (2005) HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J. Exp. Med. 202, 1493-1505
39. Eltzschig, H. K., and Carmeliet, P. (2011) Hypoxia and inflammation. N. Engl. J. Med. 364, 656-665
40. Semenza, G. (2002) Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64, 993-998
41. Minet, E., Michel, G., Remacle, J., and Michiels, C. (2000) Role of HIF-1 as a transcription factor involved in embryonic development, cancer progression and apoptosis (review). Int. J. Mol. Med. 5, 253-259
42. Semenza, G. L. (2001) HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13, 167-171
43. Kong, T., Westerman, K. A., Faigle, M., Eltzschig, H. K., and Colgan, S. P. (2006) HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 20, 2242-2250
44. Yang, M., Ma, C., Liu, S., Shao, Q., Gao, W., Song, B., Sun, J., Xie, Q., Zhang, Y., Feng, A., Liu, Y., Hu, W., and Qu, X. (2010) HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia. Immunol. Cell Biol. 88, 165-171
45. Fadeel, B., Orrenius, S., and Zhivotovsky, B. (1999) Apoptosis in human disease: A new skin for the old ceremony? Biochem. Biophys. Res. Commun. 266, 699-717
46. Fadeel, B., and Orrenius, S. (2005) Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J. Int. Med. 258, 479-517